Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.73 |
| ▸ | SLC22A12 | Q96S37 | 7/20 | 0.56 |
| ▸ | EYA3 | Q99504 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | TTR | P02766 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | EYA2 | O00167 | 1/20 | 0.51 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.51 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30258464 | 0.89 | CYP2C19 (0.73) | CYP2C19SLC22A12EYA3LMNAHTT | |
| SCHEMBL20280639 | 0.86 | CYP2C19 (0.70) | CYP2C19SLC22A12EYA3LMNAHTT | |
| SCHEMBL30357377 | 0.83 | SLC22A12 (0.81) | CYP2C19SLC22A12EYA3LMNATTR | |
| SCHEMBL20280646 | 0.81 | CYP2C19 (0.65) | CYP2C19SLC22A12EYA3LMNAHTT | |
| SCHEMBL15019934 | 0.79 | SLC26A4 (0.64) | LMNAHTTMEN1KMT2AALDH1A1 | |
| SCHEMBL25392883 | 0.79 | TTR (0.77) | CYP2C19SLC22A12EYA3LMNATTR | |
| SCHEMBL20280750 | 0.78 | CYP2C19 (0.70) | CYP2C19SLC22A12EYA3LMNATTR | |
| SCHEMBL29853045 | 0.75 | GAA (0.55) | LMNAHTTMEN1KMT2AUSP2 | |
| SCHEMBL15020039 | 0.75 | GAA (0.55) | LMNAHTTMEN1KMT2AUSP2 | |
| SCHEMBL30258695 | 0.74 | SLC22A12 (0.80) | CYP2C19SLC22A12EYA3LMNATTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | INNOVO THERAPEUTICS INC. (KR) | 2025-09-11 | — | — | US | claimed |
| EP-4413981-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Innovo Therapeutics Inc. (KR) | 2024-08-14 | — | — | EP | claimed |
| CN-118043043-A | Benzofuranyl hydroxy phenyl ketone derivative compound or pharmaceutically acceptable salt thereof | 因诺沃治疗有限公司 | 2024-05-14 | — | — | CN | claimed |
| WO-2023059121-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | (주)이노보테라퓨틱스 | 2023-04-13 | — | — | WO | claimed |
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | INNOVO THERAPEUTICS INC. (KR) | 2025-09-11 | — | — | US | disclosed |
| EP-4413981-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Innovo Therapeutics Inc. (KR) | 2024-08-14 | — | — | EP | disclosed |
| CN-118043043-A | Benzofuranyl hydroxy phenyl ketone derivative compound or pharmaceutically acceptable salt thereof | 因诺沃治疗有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023059121-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | (주)이노보테라퓨틱스 | 2023-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282741-A1 | NOVEL BENZOFURANYL HYDROXYPHENYL METHANONE DERIVATIVE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | HSPH1, HSP90AA1, HSPD1 | CYP2C19 1346/4885SLC22A12 815/4885EYA3 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.